Research any topic before you write.

Find related topics. | Discover entities. | See connections. | Build a topical map.

Leronlimab: Development, Mechanism of action & Overview

Leronlimab (codenamed PRO 140) is a humanized monoclonal antibody targeted against the CCR5 receptor found on T lymphocytes of the human immune system. It is being investigated as a potential therapy in the treatment of triple negative breast cancer and HIV infection.

Language: English [EN]
Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.
100%
More settings
100% 100% 100% 100% 100%

Leronlimab topic overview

The analysis highlights Development, Mechanism of action and Overview as prominent areas in the source structure around Leronlimab.

Related topics
30
Source areas
3
Connected nodes
33
Extracted relationships
39
Related term clusters
15
Bridge connections
33

What this topic covers Research coverage

Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.

Development · 14 topics
Overview · 10 topics
Mechanism of action · 6 topics

Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

ATC code
none
CAS Number
674782-26-4 Y
ChEMBL
ChEMBL2109343
ChemSpider
none
DrugBank
DB05941 Y
KEGG
D11399

Start with your topic. Discover where to go next.

Explore different angles and find fresh ideas to shape your next piece of content.

Explore all related topics Closing gaps

Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.

Overview

Development

Mechanism of action

For the semantics nerds

You can skip this section if you’re here for content ideas and keyword inspiration.

Advanced semantic analysis

How Leronlimab connects Entity context

The extracted context around Leronlimab shows recurring relationship patterns in the source. For example, Leronlimab → ART, ASM Microbe, August, BLA, CytoDyn, Cytodyn Inc, FDA, HAART, HIV, HIV RNA, HIV-1 RNA, HIV-infected, In December, In February, In March, In May, January, Participants, PRO, PRO140 Another extracted example is Leronlimab → CD10, CD12, COVID-19, CytoDyn, Inc. Use these groups to spot repeated connection types before inspecting the individual relationships.

Leronlimab

Top relations

related to Development · 22
Leronlimab → ART, ASM Microbe, August, BLA, CytoDyn, Cytodyn Inc, FDA, HAART, HIV, HIV RNA, HIV-1 RNA, HIV-infected, In December, In February, In March, In May, January, Participants, PRO, PRO140
related to COVID-19 · 5
Leronlimab → CD10, CD12, COVID-19, CytoDyn, Inc
ATC code · 1
Leronlimab → none
CAS Number · 1
Leronlimab → 674782-26-4 Y
ChEMBL · 1
Leronlimab → ChEMBL2109343
ChemSpider · 1
Leronlimab → none
DrugBank · 1
Leronlimab → DB05941 Y
KEGG · 1
Leronlimab → D11399
NIAID ChemDB · 1
Leronlimab → 088103
Other names · 1
Leronlimab → PRO 140

Important terminology

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

pro 140 cytodyn patients ccr5 hiv antibody trial treatment breast 2019 cancer drug covid-19 viral monoclonal also humanized fda mtnbc

Leronlimab relationships Subject–Predicate–Object triples

TTTA extracted 39 structured relationships around Leronlimab. Examples in this analysis include Leronlimab → ATC code → none and Leronlimab → CAS Number → 674782-26-4 Y. The table shows each extracted connection, where it came from and its confidence.

SubjectPredicateObjectConfidenceSrc
LeronlimabATC codenone1.00infobox
LeronlimabCAS Number674782-26-4 Y1.00infobox
LeronlimabChEMBLChEMBL21093431.00infobox
LeronlimabChemSpidernone1.00infobox
LeronlimabDrugBankDB05941 Y1.00infobox
LeronlimabKEGGD113991.00infobox
LeronlimabNIAID ChemDB0881031.00infobox
LeronlimabOther namesPRO 1401.00infobox
LeronlimabSourceHumanized1.00infobox
LeronlimabTargetCCR51.00infobox
LeronlimabTypeWhole antibody1.00infobox
LeronlimabUNIIY1J4NP8FF01.00infobox

Related concept clusters Related term clusters

The concept neighborhoods around Leronlimab bring nearby vocabulary together. In this analysis, examples include Cytodyn, Also and Patients. Use the clusters to find adjacent concepts and terminology that may deserve separate research.

  • Leronlimab
    • Cytodyn
    • Also
    • Patients
    • Treatment
    • Hiv
    • Combination
    • Pro140
    • Covid-19
    • Drug
    • Pro
    • Antibody
    • Ccr5
  • leronlimab
    • Cytodyn
    • Also
    • Patients
    • Treatment
    • Hiv
    • Combination
    • Pro140
    • Covid-19
    • Drug
    • Pro
    • Antibody
    • Ccr5
  • triple negative breast cancer
    • Cancer
    • Cytodyn
    • Treatment
    • Investigated
    • Infection
    • Approval
    • Clinical
    • Compared
    • Phase
    • Potential
    • Received
    • Therapy
  • hiv infection
    • Therapy
    • Combination
    • Investigated
    • Trial
    • Infection
    • Leronlimab
    • Pro140
    • Cytodyn
    • Entry
    • Potential
    • Primary
    • Treatment
  • stomach cancer
    • Cytodyn
    • Treatment
    • Investigated
    • Infection
    • Approval
    • Clinical
    • Compared
    • Phase
    • Potential
    • Received
    • Receptor
    • Therapy
  • food and drug administration
    • Patients
    • Pro
    • Leronlimab
    • Approval
    • Clinical
    • Combination
    • Days
    • May
    • Phase
    • Potential
    • Results
    • Covid-19
  • breast
    • Cancer
    • Cytodyn
    • Investigated
    • Infection
    • Approval
    • Clinical
    • Compared
    • Phase
    • Potential
    • Received
    • Therapy
    • Fda
  • clinical trial
    • Phase
    • Trial
    • Mtnbc
    • May
    • Potential
    • Received
    • Results
    • Covid-19
    • Fda
    • Drug
    • Treatment
    • Pro140

Connections between topic areas Semantic bridges

For Leronlimab, one of the stronger structural bridges in this analysis connects Leronlimab with Development. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.

Min side: 3
Leronlimab — Development · splits 19 ⟂ 15
Leronlimab — Overview · splits 23 ⟂ 11
Leronlimab — Mechanism of action · splits 27 ⟂ 7

Map overview Semantic statistics

Leronlimab

Nodes34
Edges33
Triples39
Avg. degree1.94
Density0.058824
Components1

Source & methodology

TTTA analyzes the structure around Leronlimab to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Development, Mechanism of action & Overview, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.

Source: Wikipedia — Leronlimab · EN edition · Analysis: TopicsToTalkAbout

For writers, content strategists, SEOs, marketers and creators — from quick topic research to advanced semantic analysis.

Monitor your Domain Rating with FrogDR